Estimativas de analistas de Wall Street para Bioventus Inc. (BVS): preço alvo de consenso, recomendações de compra/manter/venda e previsões de receita, LPA e EBITDA para os próximos exercícios.
Surpresas de Resultados Recentes
| Data | LPA Real | LPA Estimado | vs Est. |
|---|---|---|---|
| 2026-11-03 | $0.17 | ||
| 2026-08-05 | $0.22 | $0.22 | +1.7% |
| 2026-05-06 | $0.15 | $0.09 | +66.7% |
| 2026-03-05 | $0.24 | $0.22 | +9.1% |
| 2025-11-04 | $0.15 | $0.21 | -30.2% |
| 2025-08-06 | $0.21 | $0.22 | -4.5% |
| 2025-05-06 | $0.08 | $0.06 | +33.3% |
| 2025-03-11 | $0.15 | $0.08 | +87.5% |
Índices de avaliação
| Índice P/L | 15.25 |
| Preço / Valor contábil | 3.64 |
| EV / EBITDA | 12.06 |
| Dividend Yield | 0.00% |
Demonstração de Resultados (10 anos)
| Ano | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Receita | $274.5M | $292.1M | $319.2M | $340.1M | $321.2M | $430.9M | $512.1M | $512.3M | $573.3M | $568.1M |
| Custo da Receita | $91.4M | $92.1M | $84.2M | $90.9M | $87.6M | $128.2M | $181.0M | $184.2M | $185.1M | $185.7M |
| Lucro Bruto | $183.1M | $200.0M | $235.0M | $249.2M | $233.5M | $302.7M | $331.1M | $328.2M | $388.2M | $382.4M |
| P&D | $7.9M | $8.1M | $8.1M | $11.1M | $11.2M | $19.0M | $23.9M | $13.4M | $13.6M | $12.1M |
| Despesas Gerais e Administrativas | $160.3M | $164.8M | $191.7M | $198.5M | $193.1M | $254.3M | $332.1M | $303.9M | $327.1M | $311.8M |
| Despesas Operacionais | $168.2M | $172.9M | $209.5M | $218.0M | $212.3M | $290.6M | $498.3M | $409.9M | $400.2M | $323.9M |
| Lucro Operacional | $14.9M | $27.0M | $25.5M | $31.2M | $21.2M | $12.1M | -$167.2M | -$81.7M | -$12.0M | $58.5M |
| EBITDA | $44.0M | $59.8M | $54.5M | $61.6M | $54.3M | $45.5M | -$121.6M | -$23.1M | $39.2M | $99.2M |
| Despesas com Juros | $15.9M | $18.9M | $19.2M | $21.6M | $9.8M | $1.1M | $12.0M | $40.7M | $38.8M | $26.5M |
| Lucro Antes de Impostos | -$5.7M | $8.7M | $6.1M | $9.7M | $15.9M | $9.5M | -$189.0M | -$121.1M | -$49.1M | $25.7M |
| Imposto | $1.1M | -$785000 | $1.7M | $1.6M | $1.2M | -$2.0M | -$44.4M | $85000 | -$5.3M | -$1.6M |
| Lucro Líquido | -$18.0M | -$1.6M | -$12.2M | $6.9M | $16.4M | $19.4M | -$158.7M | -$156.2M | -$33.5M | $22.7M |
| LPA | $-0.41 | $-0.13 | $-0.22 | $0.12 | $0.44 | $0.43 | $-2.59 | $-2.49 | $-0.52 | $0.34 |
| LPA Diluído | $-0.41 | $-0.13 | $-0.22 | $0.12 | $0.44 | $0.43 | $-2.59 | $-2.49 | $-0.52 | $0.33 |
| Ações em Circulação (Diluídas) | $56.8M | $56.8M | $56.8M | $56.8M | $37.7M | $45.5M | $61.4M | $62.6M | $65.4M | $68.9M |
Preço
| Preço | $13.20 |
| Capitalização | $894M |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: AVNS · BFLY · CBLL · CTKB · KIDS · LAB · SMLR
Explorar setor: Healthcare · Medical - Devices
Mais seções de BVS: Resumo · Financeiros · Avaliação · Estatísticas · Técnico · Propriedade · Notícias · Eventos
Descubra mais: Radar — sinais de ações subvalorizadas · Academia de Investimento — aprenda a analisar ações